scholarly journals Long-Term Survival of Resected Advanced Gastric Cancer with Hepatic and Pancreatic Invasion

2011 ◽  
Vol 5 (2) ◽  
pp. 396-403
Author(s):  
Hiromitsu Domen ◽  
Masanori Ohara ◽  
Misa Noguchi ◽  
Yoshitsugu Nakanishi ◽  
Kazuteru Komuro ◽  
...  
2017 ◽  
Vol 10 (1) ◽  
pp. 217-225
Author(s):  
Byoung Jo Suh

We report the case of a noncuratively resected gastric cancer patient who was successfully treated with S-1 monotherapy, resulting in long-term survival of 96 months. A 72-year-old woman underwent noncurative resection of subtotal gastrectomy for advanced gastric cancer with conglomerated lymph node metastasis and pancreatic invasion. She received chemotherapy with S-1 monotherapy postoperatively. S-1 (100 mg/day) was administered orally after breakfast and dinner for 28 days followed by a 14-day break for a total of 52 months. Regular checkups with esophagogastroduodenoscopy, abdominopelvic computed tomography, and fluorine-18-fluorodeoxyglucose positron emission tomography revealed no evidence of cancer 96 months after the operation. The patient was effectively treated with long-term administration of S-1 after noncurative gastrectomy for advanced gastric cancer.


2021 ◽  
pp. 67-72
Author(s):  
Sung Jin Oh

Liver metastasis from gastric cancer has a very poor prognosis. Herein, we present two cases of liver metastases (synchronous and metachronous) from advanced gastric cancer. In the first case, the patient underwent radical subtotal gastrectomy. Liver metastases occurred 6 months after surgery while the patient was receiving adjuvant chemotherapy, but two hepatic tumors were successfully removed by radiofrequency ablation (RFA). In the second case, liver metastases occurred 15 months after surgery for gastric cancer. The patient also received RFA for one hepatic tumor, and other suspicious metastatic tumors were treated with systemic chemotherapy. Although these case presentations are limited for the efficacy of RFA treatment with systemic chemotherapy for hepatic metastases from gastric cancer, our findings showed long-term survival (overall survival for 108 and 67 months, respectively) of the affected patients, without recurrence. Therefore, we suggest that RFA treatment with systemic chemotherapy could be an effective alternative treatment modality for hepatic metastases from gastric cancer.


1990 ◽  
Vol 45 (3) ◽  
pp. 169-172 ◽  
Author(s):  
Yoshihiko Maehara ◽  
Sunao Moriguchi ◽  
Yoshihisa Sakaguchi ◽  
Yasunori Emi ◽  
Shunji Kohnoe ◽  
...  

2013 ◽  
Vol 4 (11) ◽  
pp. 976-980 ◽  
Author(s):  
Takashi Orii ◽  
Yukihiko Karasawa ◽  
Hiroe Kitahara ◽  
Masaki Yoshimura ◽  
Motohiro Okumura

1998 ◽  
Vol 59 (7) ◽  
pp. 1838-1841 ◽  
Author(s):  
Hitoshi SHIBUYA ◽  
Rikuo NISHIDA ◽  
Masashi NAKANO ◽  
Toshio HOMMA ◽  
Chikashi KIHARA

Sign in / Sign up

Export Citation Format

Share Document